COVID 19 - Business Support

March 19, 2020

No items found.

We are now working remotely due to COVID-19.

We exist to support innovative businesses to grow and succeed, and we want to continue to do this as effectively as possible throughout this crisis

We love meeting with clients, and although face-to-face meetings are postponed for a while, our advisors are still chatting with clients on the phone, and we've been enjoying video conference calls with both colleagues and clients

We appreciate that things aren't as straightforward for some of our clients, and we hope you’re managing to find suitable ways forward for your business
‍

How we'd like to help
‍
If you've wanted to catch up with us for a while, and you now have some time for planning, we’d love to hear from you

Our portfolio of services includes free business support services through our EEN team
We provide free R&D Tax Credit reviews to check that you're maximising your claim
We're helping some of our clients to bring forward their year end, so that they can make their R&D Tax Credit claim earlier
If you are conducting R&D related to the COVID-19 outbreak, we will process your R&D Tax Credit claim for free for one year

‍Please get in touch for an informal chat by ringing 01925 506100 or emailing info@inventya.com

‍

We're using the following sources of information during this time:‍

Guidance for Businesses

UK Government Guidance – for employees, employers and businesses

UK Government Financial Support for Businesses

UK Government Support Helplines for Businesses

Innovate UK Business Support

Intellectual Property Office

KTN

‍

Resources for Individuals

UK Government Guidance for Employees - including sick pay, furloughed workers, claiming benefits,

UK Government COVID-19 - what you need to do

NHS

‍

Tax and Accounts

HMRC Tax Helpline

Companies House - Filing Accounts

‍

Financial Support

UK Government Support for Businesses

‍Coronavirus Business Interruption Loan Scheme

Lloyds Banking Group SME Support

NatWest Support for SMEs

‍

Growth Hub Resources

Cheshire and Warrington

‍

Funding calls for researching COVID-19

See this page for COVID-19-related funding calls

‍

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML

Downloaded from here cropped to size

March 19, 2020

← back to news

General

Thank you! We will be in touch shortly.

Oops! Something went wrong while submitting the form.

Your privacy matters | View our privacy policy

More of our news

The Human Element: Balancing Technology and Empathy in a Hyperconnected World

In our hyperconnected world, technology has transformed the way we communicate and interact with each other. From smartphones and social media to video calls and virtual reality, we rely on technology to connect with others, access information, and streamline our tasks. While technology and its evolution have undoubtedly brought many benefits, it has also led to concerns about the erosion of the human element in our interactions.

May 18, 2023

Unlocking the Power of International Collaboration: How Working with Partners Abroad Can Benefit Your R&D Activities

It's no secret that we're living in a hyperconnected world, where challenges can feel overwhelming as we huddle behind our screens. However, collaboration is the key that unlocks the door to enduring solutions, and we've witnessed this first-hand during the COVID-era. Global communities united to contain the spread, develop vaccines, and establish effective treatments. This joint effort played a crucial role in restoring a semblance of order amidst the chaos.

May 11, 2023

What to Consider When Choosing Your Grant Writer – the Importance of the Human Touch

Over the past two decades of writing grant applications, I've experienced the transformation of government funding. When InnovateUK was still called the 'Technology Strategy Board,' many businesses were unaware of available grants, and some were hesitant, thinking that such non-repayable funding was too good to be true.

May 3, 2023

Navigating the Ethical Crossroads: Striking the Balance between Grant Compliance and Innovation

In a world where market disruption and system modernisation are the norm, grant-funded projects face the challenge of balancing compliance and innovation. On the one hand, strict regulations ensure ethical conduct and resource allocation, while on the other, innovation is essential for solving complex problems and driving progress.

April 19, 2023

Unlocking the Potential of Sustainable Technologies: How R&D Tax Credits Can Pave the Way

Unlock the potential of sustainable technologies and pave the way towards a greener future with R&D Tax Credits. Learn how this government incentive can help your business reduce costs, improve cash flow, and drive innovation for environmental sustainability.

April 3, 2023

Common mistakes to avoid when writing a grant proposal

Key to writing a good grant proposal is to be diligent, focused and persistent. By avoiding common mistakes like lack of clarity, unrealistic budgeting, and failure to meet the funder’s priorities, you can increase your chances of getting grant approvals. Carefully plan your proposal while adhering to the submission guidelines and stay true to your project vision to bring your project to life.

March 14, 2023

COVID 19 - Business Support

March 19, 2020

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab. Credit: NIAID-RML

Downloaded from here cropped to size

More of our news

Keep up to date with our latest news and updates

Read our privacy policy

Commercial Services

Innovate UK EDGE

Contact

Social Links

Other

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML